Clinical trial

A Study in Painful Diabetic Neuropathy

NCT01089556

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-03-01

PhasePHASE3

Study timeline

Study start (unknown)2010-03-01Date precision: month

Registry last updated2013-01-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Neuropathy, Painfulunresolved

Interventions

DuloxetineDRUG · verified · RxNorm: duloxetine

PregabalinDRUG · verified · RxNorm: pregabalin

PlaceboDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Boehringer Ingelheimcollaborator

Mapped research locations

SeoulSouth Korea1 ParisFrance1 MilanItaly1 ValenciaSpain1 VancouverBritish Columbia, Canada1 NaplesItaly1 StockholmSweden1 AnkaraTurkey (Türkiye)1 AthensGreece1 DresdenGermany1 WroclawPoland1 BialystokPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01089556 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.